Study programme
Classes
- Xenobiochemistry +1GAF237 | Faculty of Pharmacy in Hradec Králové
- General Biochemistry +1GAF141 | Faculty of Pharmacy in Hradec Králové
- Xenobiochemistry - Practical Training +3GAF267 | Faculty of Pharmacy in Hradec Králové
- Selected Chapters from General Biochemistry +1GDEXP04 | Faculty of Pharmacy in Hradec Králové
- The Defense of Doctoral Thesis +1GDEXPODP1 | Faculty of Pharmacy in Hradec Králové
- Xenobiochemistry and Patobiochemistry +1GDEXPSDZ1 | Faculty of Pharmacy in Hradec Králové
Publications
- Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro2013 | Faculty of Pharmacy in Hradec Králové
- Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily2012 | Faculty of Pharmacy in Hradec Králové
- Liquid chromatographic-electrospray mass spectrometric determination (LC-ESI-MS) of phase II metabolites of flobufen in rat liver microsomes - Chiral discrimination2008 | Central Library of Charles University
- Metabolic study of potential antileukotrienic drug quinlukast (VUFB 19363) in male rats in vitro.2002 | Publication without faculty affiliation
- Conjugation of Flobufen and its metabolites in male rats2002 | Publication without faculty affiliation
- Preliminary study of Phase II biotransformation of Flobufen in male rats2002 | Publication without faculty affiliation
- Central composite design as a powerful optimisation technique for enantioresolution of the rac-11-dihydrooracin - the principal metabolite of the potential cytostatic drug oracin2002 | Publication without faculty affiliation
- Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux2022 | Faculty of Pharmacy in Hradec Králové
- Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters2022 | Faculty of Pharmacy in Hradec Králové
- Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib2021 | Faculty of Pharmacy in Hradec Králové
Loading network view...